Assessing effects of pneumococcal vaccination (PCV13) and rotavirus vaccination (RV) on colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in Guatemalan children
Brooke M. Ramay , Jonathan Yoder , Carmen Castillo , Natalie Fahsen , Laura Grajeda , Lucas F. Santos , Juan Carlos Romero , Maria Renee Lopez , Guy H. Palmer , Celia Cordon-Rosales , Douglas R. Call
{"title":"Assessing effects of pneumococcal vaccination (PCV13) and rotavirus vaccination (RV) on colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in Guatemalan children","authors":"Brooke M. Ramay , Jonathan Yoder , Carmen Castillo , Natalie Fahsen , Laura Grajeda , Lucas F. Santos , Juan Carlos Romero , Maria Renee Lopez , Guy H. Palmer , Celia Cordon-Rosales , Douglas R. Call","doi":"10.1016/j.vaccine.2025.127852","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>We aimed to determine if vaccination against rotavirus (RV) or pneumococcus (PCV13) is associated with reduced colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in children (<15 years) living in Guatemala.</div></div><div><h3>Methods</h3><div>Questionnaire information, vaccine records, and stool samples were collected from enrolled participants. Specimens were plated onto selective media with antibiotic susceptibility confirmed using a VITEK®2. We employed an instrumental variables approach with maximum likelihood for a system of three nested probit regression equations for binary outcomes of RV or PCV13 vaccination, diarrhea or clinic visits, and ESCrE colonization.</div></div><div><h3>Results</h3><div>Participants (<em>n</em> = 406) ranged from 0 to 14 years old, 123 (30.3 %) were 0–2 years old, 103 (25.4 %) were 3–5 years old, and 180 (44.3 %) were 6–14 years old. PCV13 vaccination had indirect negative effects on ESCrE colonization (−0.092, <em>P</em> < 0.01) mediated through clinic visits (−0.461, <em>P</em> < 0.01), while antibiotic use had a direct positive effect on clinic visits (0.226, <em>P</em> < 0.01), but no significant effects on ESCrE colonization. Effects of RV on ESCrE colonization were inconclusive likely due to the limited sample size of RV-unvaccinated children. Protective effects of yogurt consumption on ESCrE colonization (−0.064, <em>P</em> < 0.01; −0.062, <em>P</em> < 0.01) and positive direct effects of land used for agriculture (0.232, <em>P</em> < 0.01; 0.224, P 〈001) were detected in both RV and PCV13 models, respectively. Report of diarrhea in the past 30 days had a direct positive effect on colonization (0.731, <em>P</em> < 0.01) in the RV model, and indirect positive effects on ESCrE colonization (0.090, <em>P</em> < 0.01) in the PCV13 model.</div></div><div><h3>Interpretation</h3><div>Vaccination for pneumococcal disease was associated with a reduction in colonization with ESCrE bacteria. Antibiotic use did not contribute directly or indirectly to ESCrE colonization. These findings should be confirmed through studies designed to collect clinical outcomes data. Findings from this and other studies suggest that ESCrE colonization is mediated by a complex interplay of factors.</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"66 ","pages":"Article 127852"},"PeriodicalIF":4.5000,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X25011491","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
We aimed to determine if vaccination against rotavirus (RV) or pneumococcus (PCV13) is associated with reduced colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in children (<15 years) living in Guatemala.
Methods
Questionnaire information, vaccine records, and stool samples were collected from enrolled participants. Specimens were plated onto selective media with antibiotic susceptibility confirmed using a VITEK®2. We employed an instrumental variables approach with maximum likelihood for a system of three nested probit regression equations for binary outcomes of RV or PCV13 vaccination, diarrhea or clinic visits, and ESCrE colonization.
Results
Participants (n = 406) ranged from 0 to 14 years old, 123 (30.3 %) were 0–2 years old, 103 (25.4 %) were 3–5 years old, and 180 (44.3 %) were 6–14 years old. PCV13 vaccination had indirect negative effects on ESCrE colonization (−0.092, P < 0.01) mediated through clinic visits (−0.461, P < 0.01), while antibiotic use had a direct positive effect on clinic visits (0.226, P < 0.01), but no significant effects on ESCrE colonization. Effects of RV on ESCrE colonization were inconclusive likely due to the limited sample size of RV-unvaccinated children. Protective effects of yogurt consumption on ESCrE colonization (−0.064, P < 0.01; −0.062, P < 0.01) and positive direct effects of land used for agriculture (0.232, P < 0.01; 0.224, P 〈001) were detected in both RV and PCV13 models, respectively. Report of diarrhea in the past 30 days had a direct positive effect on colonization (0.731, P < 0.01) in the RV model, and indirect positive effects on ESCrE colonization (0.090, P < 0.01) in the PCV13 model.
Interpretation
Vaccination for pneumococcal disease was associated with a reduction in colonization with ESCrE bacteria. Antibiotic use did not contribute directly or indirectly to ESCrE colonization. These findings should be confirmed through studies designed to collect clinical outcomes data. Findings from this and other studies suggest that ESCrE colonization is mediated by a complex interplay of factors.
期刊介绍:
Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.